• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    More On SKP.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Skyepharma PLC (SKP.L)

    -LSE
    324.75 Up 3.25(1.01%) 4:06AM EST
    Add to Portfolio
    Prev Close:321.50
    Open:325.00
    Bid:321.25
    Ask:324.75
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:319.56 - 325.25
    52wk Range:108.20 - 379.19
    Volume:23,354
    Avg Vol (3m):329,254
    Market Cap:213.36M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Headlines

    • No Headlines available for SKP.L at this time.

    Key Statistics

    Forward P/E (1 yr):0.12
    P/S (ttm):321.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :16.15
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Skyepharma PLC develops oral and inhalation pharmaceutical products. The company’s products include flutiform, a unique inhaled combination product which has been approved in 31 countries; and Pacira’s Exparel, an amide local anesthetic ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback